Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Zosyn	O
/	O
ceftriaxone	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Unresponsiveness,	O
altered,	B-Delirium
intubated	O
for	O
airway	O
protection	O
found	O
to	O
have	O
urosepsis	B-Urinary_tract_infection
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
intubated,	O
mechanical	O
ventilation	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
female	O
with	O
MS	O
on	O
tegretol	O
for	O
questionable	O
hx	O
TMJ	O
who	O
was	O
sent	O
in	O
from	O
her	O
___	O
after	O
being	O
found	O
covered	O
in	O
vomit	O
with	O
agonal	O
breathing.	O
___	O
notes	O
reports	O
"symptoms	O
of	O
seizure	B-Seizures
activity"	O
with	O
patient	O
subsequently	O
unresponsive	O
and	O
found	O
to	O
be	O
hypoxic	O
with	O
sats	O
<83%	O
on	O
2L.	O
Per	O
EMS,	O
she	O
was	O
unresponsive	O
en	O
route,	O
still	O
breathing	O
but	O
not	O
withdrawing	O
to	O
pain.	O
.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were:	O
no	O
temp	O
recorded,	O
118	O
135/71	O
34	O
100%	O
on	O
NRB.	O
She	O
was	O
easily	O
intubated	O
for	O
airway	O
protection	O
with	O
a	O
grade	O
1	O
view.	O
Head	B-Intracranial_haemorrhage
CT	B-Intracranial_haemorrhage
was	O
unremarkable	O
for	O
bleed.	B-Intracranial_haemorrhage
Neuro	O
was	O
consulted	O
and	O
felt	O
this	O
was	O
likely	O
toxic	O
metabolic	O
if	O
seizure	B-Seizures
activity,	O
but	O
will	O
continue	O
to	O
follow.	O
She	O
has	O
had	O
multiple	O
episodes	O
of	O
UTI	B-Urinary_tract_infection
in	O
the	O
past.	O
Blood	O
and	O
urine	O
cultures	O
were	O
sent	O
and	O
she	O
was	O
given	O
vanco/zosyn.	O
Foley	O
was	O
changed.	O
Per	O
the	O
ED	O
resident,	O
they	O
were	O
not	O
aware	O
of	O
her	O
potential	O
allergy	O
but	O
she	O
did	O
not	O
have	O
a	O
rash	O
prior	O
to	O
transfer	O
to	O
the	O
MICU.	O
When	O
the	O
patient	O
was	O
signed	O
out	O
she	O
was	O
currently	O
doing	O
well	O
on	O
vent	O
with	O
most	O
recent	O
vitals	O
prior	O
to	O
transfer	O
being	O
afeb,	O
92,	O
103/60	O
with	O
sats	O
100%	O
on	O
400x18,	O
5x50%.	O
She	O
dropped	O
her	O
pressures	O
prior	O
to	O
transfer	O
to	O
67/41	O
with	O
HR	O
94.	O
She	O
was	O
given	O
2L	O
of	O
IVF	O
and	O
started	O
on	O
levophed.	O
Sedation	O
was	O
held.	O
.	O
Of	O
note,	O
per	O
Dr.	O
___	O
note	O
to	O
her	O
PCP,	O
her	O
last	O
admission	O
was	O
for	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection,	B-Urinary_tract_infection
E.	O
coli	O
bacteremia,	O
and	O
sepsis,	O
and	O
initially	O
required	O
admission	O
to	O
the	O
ICU	O
for	O
vasopressor	O
support.	O
She	O
was	O
also	O
found	O
to	O
have	O
an	O
obstructing	O
left	O
renal	O
stone	O
and	O
had	O
a	O
percutaneous	O
nephrostomy	O
tube	O
placed	O
with	O
improvement	O
in	O
her	O
infection.	O
She	O
was	O
able	O
to	O
be	O
taken	O
of	O
vasopressor	O
agents	O
and	O
was	O
discharged	O
to	O
complete	O
a	O
14	O
day	O
total	O
course	O
of	O
antibiotics.	O
At	O
that	O
time,	O
urology	O
recommended	O
to	O
leave	O
the	O
nephrostomy	O
tube	O
in	O
the	O
left	O
renal	O
system	O
indefinitely	O
with	O
tube	O
changes	O
every	O
3	O
months	O
as	O
she	O
was	O
high	O
risk	O
for	O
both	O
nephrolithotomy	O
and	O
extracorporeal	O
shock	O
wave	O
lithotripsy.	O
Her	O
hospital	O
course	O
was	O
also	O
notable	O
for	O
hypoxia	O
with	O
a	O
4L	O
oxygen	O
requirement	O
which	O
was	O
felt	O
to	O
be	O
due	O
to	O
a	O
combination	O
of	O
mild	O
volume	O
overload,	O
respiratory	O
muscle	O
weakness	O
in	O
the	O
setting	O
of	O
multiple	O
sclerosis	O
and	O
infection,	O
and	O
intermittent	O
aspiration.	O
Her	O
oxygen	O
requirement	O
was	O
stable	O
and	O
she	O
was	O
discharged	O
to	O
rehab	O
to	O
have	O
gentle	O
diuresis	O
as	O
tolerated	O
and	O
tocontinue	O
her	O
usual	O
dysphagia	O
diet.	O
She	O
has	O
been	O
on	O
2L	O
at	O
her	O
___	O
with	O
unclear	O
continued	O
workup.	O
.	O
Past	O
Medical	O
History:	O
Multiple	O
Sclerosis	O
-	O
about	O
___,	O
followed	O
by	O
___	O
at	O
___	O
-	O
wheelchair	B-Mobile_with_aid
at	O
baseline,	O
lives	O
in	O
nursing	B-Lives_in_carehome
home	B-Lives_in_carehome
-	O
has	O
no	O
use	O
of	O
her	O
lower	O
extremities,	O
sometimes	O
spastic	O
movements	O
-	O
bladder	O
chronically	O
contracted	O
UTI	B-Urinary_tract_infection
with	O
ESBL	O
E.coli--sensitive	O
to	O
zosyn,	O
___,	O
gent	O
in	O
past	O
Chronic	O
Depression	O
Anxiety	O
PVD	O
s/p	O
lower	O
extremity	O
bypass	O
COPD	O
Osteoporosis	O
Hx	O
of	O
+PPD	O
bilateral	O
femur	O
supracondylar	O
fractures	O
___	O
hx	O
of	O
Urosepsis	B-Urinary_tract_infection
-	O
hospitalized	O
about	O
once/yr,	O
per	O
husband	O
___	O
bladder	O
-	O
indwelling	O
foley	O
x	O
___	O
yrs,	O
per	O
husband	O
___	O
C.	O
___	O
Hx	O
of	O
Sacral	O
___	O
___	O
spasticity	O
Hx	O
of	O
jaw	O
pain	O
--	O
?TMJ,	O
improved	O
on	O
Tegretol	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
members	O
with	O
Multiple	O
___.	O
Physical	O
Exam:	O
Admission	O
exam	O
Vitals:	O
101.9	O
100	O
117/64	O
17	O
100%	O
on	O
400x18,	O
5x50%	O
General:	O
Intubated,	O
sedated,	O
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear,	O
EOMI,	O
PERRL,	O
blood	O
around	O
mouth,	O
no	O
lesions	O
identified	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
CV:	O
RRR,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Lungs:	O
CTAB,	O
no	O
wheezes,	O
rales,	O
ronchi	O
Abdomen:	O
+BS,	O
soft,	O
non-tender,	O
non-distended,	O
no	O
organomegaly	O
Back:	O
stage	O
2	O
sacral	B-Pressure_injury
___	O
on	O
right	O
buttocks,	B-Pressure_injury
stage	O
1	O
___	O
on	O
left	O
hip,	B-Pressure_injury
left	O
perc	O
neph	O
tube	O
in	O
place	O
and	O
c/d/i	O
GU:	O
+foley	O
Ext:	O
cool,	O
well	O
perfused,	O
2+	O
pulses	O
distally,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema,	O
moving	O
her	O
toes,	O
PICC	O
line	O
in	O
right	O
upper	O
arm	O
is	O
c/d/i	O
Neuro:	O
sedated	O
Discharge	O
Exam:	O
Afebrile	O
Gen:	O
Alert,	O
awake,	O
responding	O
appropriately	O
to	O
questions,	O
soft	O
spoken	O
with	O
some	O
slurring	O
of	O
speech	O
HEENT:	O
dry	O
MM	O
CV:	O
RRR,	O
no	O
MRG	O
Lungs:	O
poor	O
inspiratory	O
effort,	O
no	O
wheezes,	O
crackles,	O
consolidations	O
Abd:	O
+BS,	O
soft,	O
NT,	O
surgical	O
scars	O
Back:	O
___	O
GU:	O
Foley	O
and	O
left	O
perc	O
nephrostomy	O
CDI	O
Neuro:	O
baseline	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
01:49PM	O
GLUCOSE-103*	O
UREA	O
N-16	O
CREAT-0.7	O
SODIUM-142	O
POTASSIUM-4.2	O
CHLORIDE-110*	O
TOTAL	O
CO2-25	O
ANION	O
GAP-11	O
___	O
01:49PM	O
CALCIUM-8.0*	O
PHOSPHATE-2.7	O
MAGNESIUM-1.8	O
___	O
06:23AM	O
CK-MB-7	O
cTropnT-0.50*	O
___	O
06:23AM	O
ALT(SGPT)-30	O
AST(SGOT)-72*	O
CK(CPK)-90	O
ALK	O
PHOS-183*	O
TOT	O
BILI-0.4	O
___	O
06:23AM	O
WBC-14.7*#	O
RBC-3.40*	O
HGB-9.9*	O
HCT-31.1*	O
MCV-91	O
MCH-29.0	O
MCHC-31.7	O
RDW-15.5	O
DISCHARGE	O
LABS:	O
___	O
06:07AM	O
BLOOD	O
WBC-6.0	O
RBC-3.09*	O
Hgb-8.6*	O
Hct-27.4*	O
MCV-89	O
MCH-27.7	O
MCHC-31.2	O
RDW-15.5	O
Plt	O
___	O
___	O
10:46AM	O
BLOOD	O
Neuts-67.6	O
___	O
Monos-4.6	O
Eos-5.1*	O
Baso-0.6	O
___	O
06:07AM	O
BLOOD	O
Glucose-75	O
UreaN-7	O
Creat-0.4	O
Na-141	O
K-3.9	O
Cl-106	O
HCO3-31	O
AnGap-8	O
___	O
05:54AM	O
BLOOD	O
ALT-16	O
AST-20	O
LD(LDH)-180	O
AlkPhos-130*	O
TotBili-0.2	O
___	O
06:07AM	O
BLOOD	O
Calcium-8.3*	O
Phos-2.9	O
Mg-2.0	O
TTE:	O
The	O
left	O
atrium	O
and	O
right	O
atrium	O
are	O
normal	O
in	O
cavity	O
size.	O
Left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal.	O
There	O
is	O
mild	O
to	O
moderate	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
hypokinesis	O
of	O
the	O
distal	O
half	O
of	O
the	O
septum	O
and	O
apical	O
anterior	O
and	O
inferior	O
walls.	O
The	O
remaining	O
segments	O
contract	O
well	O
(LVEF	O
40%).	O
The	O
apex	O
is	O
not	O
aneurysm	O
and	O
no	O
apical	O
thrombus	O
is	O
seen.	O
The	O
estimated	O
cardiac	O
index	O
is	O
normal	O
(>=2.5L/min/m2).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	O
stenosis	O
or	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	O
regurgitation.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
regional	O
systolic	O
dysfunction	O
c/w	O
CAD	O
(mid-LAD	O
distribution).	O
Pulmonary	O
artery	O
hypertension.	O
CTAbd/pelvis:	O
IMPRESSION:	O
1.	O
Foley	O
catheter	O
is	O
now	O
positioned	O
with	O
its	O
distal	O
tip	O
seen	O
in	O
the	O
right	O
ureter.	O
Repositioning	O
is	O
recommended.	O
These	O
findings	O
were	O
discussed	O
with	O
Dr.	O
___	O
Dr.	O
___	O
by	O
telephone	O
at	O
___:10	O
a.m.	O
on	O
___.	O
2.	O
Left	O
nephrostomy	O
tube	O
with	O
small	O
left	O
subcapsular	O
hematoma	O
and	O
unchanged	O
left	O
ureteropelvic	O
junction	O
stone.	O
3.	O
No	O
evidence	O
of	O
small-bowel	O
obstruction	O
despite	O
large	O
amount	O
of	O
stool	O
seen	O
within	O
the	O
rectum	O
and	O
sigmoid.	O
4.	O
Unchanged	O
right	O
renal	O
staghorn	O
calculus.	O
Renal	O
US:	O
IMPRESSION:	O
1.	O
Right	O
renal	O
stones	O
without	O
hydronephrosis.	O
2.	O
Unchanged	O
mild	O
left	O
collecting	O
system	O
fullness.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
female	O
with	O
history	O
of	O
MS	O
with	O
chronic	O
indwelling	O
foley	O
and	O
left	O
percutaneous	O
nephrostomy	O
tube	O
found	O
to	O
be	O
unresponsive	O
admitted	O
to	O
the	O
MICU	O
with	O
septic	O
shock	O
secondary	O
to	O
Pseudomonas	O
urosepsis.	B-Urinary_tract_infection
The	O
patient	O
was	O
started	O
on	O
Meropenem	O
and	O
did	O
well	O
on	O
the	O
floor.	O
.	O
1.	O
Sepsis:	O
Urosepsis	B-Urinary_tract_infection
due	O
to	O
pseudomonas	O
in	O
setting	O
of	O
obstructing	O
stone.	O
Pt	O
with	O
known	O
obstructing	O
staghorn	O
in	O
R,	O
&	O
L	O
percutaneous	O
nephrostomy	O
for	O
ureteral	O
stone.	O
The	O
patient	O
had	O
been	O
on	O
suppressive	O
ertapenem,	O
but	O
this	O
was	O
switched	O
to	O
Meropenem	O
500mg	O
IV	O
Q6hr	O
given	O
ID	O
recs	O
and	O
better	O
urinary	O
penetration.	O
ID	O
evaluated	O
the	O
patient	O
and	O
felt	O
she	O
should	O
continue	O
on	O
this	O
antibiotic	O
until	O
obstruction	O
relieved.	O
The	O
patient	O
was	O
started	O
on	O
methemazine	O
and	O
ascorbic	O
acid	O
for	O
symptomatic	O
relief.	O
Pt	O
will	O
follow	O
up	O
with	O
outpatient	O
urology	O
to	O
undergo	O
intraoperative	O
lithotripsy/stone	O
extraction.	O
.	O
2.	O
Elevated	O
troponin/Possible	O
NSTEMI:	O
Pt's	O
troponin	O
found	O
to	O
be	O
elevated	O
on	O
admission.	O
This	O
was	O
likely	O
secondary	O
to	O
demand	O
ischemia	O
in	O
the	O
setting	O
of	O
hypotension.	O
An	O
echo	O
was	O
formed	O
that	O
showed	O
wall	O
motion	O
abnormalities,	O
the	O
chronicity	O
of	O
which	O
could	O
not	O
be	O
determined.	O
The	O
patient's	O
troponin	O
trended	O
down	O
and	O
she	O
was	O
monitored	O
on	O
telemetry	O
for	O
several	O
days	O
with	O
no	O
events.	O
.	O
3.	O
Multiple	O
sclerosis:	O
The	O
patient	O
had	O
relapsing	O
and	O
remitting	O
MS	O
treated	O
with	O
Glatimer.	O
Our	O
neuro	O
colleagues	O
were	O
initially	O
consulted	O
to	O
determine	O
whether	O
her	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
was	O
neurological	O
in	O
origin.	O
They	O
determined	O
that	O
it	O
was	O
not	O
and	O
did	O
not	O
change	O
her	O
treatment	O
regimen.	O
She	O
remains	O
on	O
Baclofen,	O
Glatimer,	O
and	O
cyclobenzaprine.	O
.	O
4.	O
Hyperlipidemia:	O
Continue	O
simvastatin	O
.	O
5.	O
Depression:	O
Continue	O
citalopram	O
.	O
6.	O
CODP:	O
Respiratory	O
status	O
stable.	O
Continue	O
nebulizers/inhalers	O
.	O
7.	O
Follow	O
Up:	O
The	O
patient	O
will	O
follow	O
up	O
with	O
urology	O
for	O
elective	O
stone	O
removal.	O
She	O
will	O
continue	O
on	O
meropenem	O
until	O
urinary	O
obstruction	O
is	O
remedied.	O
.	O
Transitional	O
Issues:	O
The	O
patient	O
had	O
yeast	O
grow	O
in	O
2	O
of	O
2	O
urine	O
cultures.	O
With	O
her	O
h/o	O
urosepsis	B-Urinary_tract_infection
and	O
indwelling	O
catheters,	O
we	O
called	O
her	O
rehab	O
facility	O
and	O
recommended	O
starting	O
Fluconazole.	O
As	O
an	O
outpatient,	O
the	O
patient	O
should	O
be	O
started	O
on	O
a	O
low	O
dose	O
B-blocker	O
given	O
her	O
NSTEMI.	O
She	O
should	O
have	O
outpatient	O
cardiology	O
follow-up	O
at	O
some	O
point	O
as	O
well.	O
Medications	O
on	O
Admission:	O
1.	O
methenamine	O
hippurate	O
1	O
gram	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
bid	O
2.	O
simvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
3.	O
carbamazepine	O
100	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
one	O
daily	O
4.	O
Carbamazepine	O
100	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
Three	O
(3)	O
Tablet	O
bid	O
5.	O
baclofen	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day.	O
6.	O
glatiramer	O
20	O
mg	O
Kit	O
Sig:	O
Twenty	O
(20)	O
mg	O
Subcutaneous	O
Daily	O
7.	O
Os-Cal	O
500	O
+	O
D	O
500	O
mg(1,250mg)	O
-200	O
unit	O
Tablet	O
daily	O
8.	O
alendronate	O
70	O
mg	O
Tablet	O
PO	O
once	O
a	O
week.	O
9.	O
citalopram	O
20	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
10.	O
donepezil	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
11.	O
trazodone	O
50	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
HS	O
prn	O
insomnia.	O
12.	O
cranberry	O
250	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
13.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet	O
daily	O
14.	O
albuterol	O
sulfate	O
2.5	O
mg	O
/3	O
mL	O
(0.083	O
%)	O
Solution	O
for	O
nebs	O
q4h	O
15.	O
ipratropium	O
bromide	O
0.02	O
%	O
Solution	O
Sig:	O
One	O
(1)	O
neg	O
q6h	O
16.	O
acetaminophen	O
650	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
pain.	O
17.	O
vitamin	O
E	O
1,000	O
unit	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
daily	O
18.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
prn	O
constipation	B-Constipation
19.	O
potassium	O
chloride	O
20	O
mEq	O
Packet	O
Sig:	O
One	O
(1)daily	O
20.	O
Fleet	O
Enema	O
___	O
gram/118	O
mL	O
Enema	O
Sig:	O
One	O
(1)	O
Rectal	O
q	O
___.	O
21.	O
docusate	O
sodium	O
50	O
mg/5	O
mL	O
Liquid	O
Sig:	O
One	O
(1)	O
PO	O
BID	O
22.	O
fluticasone	O
110	O
mcg/Actuation	O
Aerosol	O
Sig:	O
Two	O
(2)	O
Puff	O
bid	O
23.	O
Sodium	O
Chloride	O
0.9%	O
Flush	O
3	O
mL	O
IV	O
Q8H:PRN	O
line	O
flush	O
q8h	O
prn	O
24.	O
Heparin	O
Flush	O
(10	O
units/ml)	O
2	O
mL	O
IV	O
PRN	O
line	O
flush	O
PICC	O
25.	O
cyclobenzaprine	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
26.	O
meropenem	O
500	O
mg	O
Recon	O
Soln	O
Sig:	O
One	O
(1)IV	O
q8	O
hours	O
for	O
5	O
days.	O
Discharge	O
Medications:	O
1.	O
methenamine	O
hippurate	O
1	O
gram	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
2.	O
simvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
baclofen	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
4.	O
Other	O
glatiramer	O
20	O
mg	O
Kit	O
Sig:	O
Twenty	O
(20)	O
mg	O
Subcutaneous	O
Daily	O
5.	O
Os-Cal	O
500	O
+	O
D	O
500	O
mg(1,250mg)	O
-200	O
unit	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
6.	O
alendronate	O
70	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
week.	O
7.	O
citalopram	O
20	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
donepezil	O
5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
9.	O
Other	O
Trazodone	O
25	O
mg	O
QHS	O
PRN	O
insomnia	O
10.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
11.	O
albuterol	O
sulfate	O
2.5	O
mg	O
/3	O
mL	O
(0.083	O
%)	O
Solution	O
for	O
Nebulization	O
Sig:	O
One	O
(1)	O
Nebulizer	O
Inhalation	O
every	O
___	O
hours	O
as	O
needed	O
for	O
SOB,	O
wheeze.	O
12.	O
ipratropium	O
bromide	O
0.02	O
%	O
Solution	O
Sig:	O
One	O
(1)	O
Nebulizer	O
Inhalation	O
every	O
___	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing.	O
13.	O
Tylenol	O
___	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
pain.	O
14.	O
vitamin	O
E	O
1,000	O
unit	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
15.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day	O
as	O
needed	O
for	O
Constipation.	B-Constipation
16.	O
potassium	O
chloride	O
20	O
mEq	O
Packet	O
Sig:	O
One	O
(1)	O
Packet	O
PO	O
once	O
a	O
day.	O
17.	O
Other	O
Fleet	O
enema	O
Q	O
___	O
18.	O
docusate	O
sodium	O
50	O
mg/5	O
mL	O
Liquid	O
Sig:	O
Two	O
(2)	O
Tablespoons	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
19.	O
fluticasone	O
110	O
mcg/Actuation	O
Aerosol	O
Sig:	O
Two	O
(2)	O
Puffs	O
Inhalation	O
twice	O
a	O
day.	O
20.	O
Heparin	O
Flush	O
(10	O
units/ml)	O
2	O
mL	O
IV	O
PRN	O
line	O
flush	O
PICC,	O
heparin	O
dependent:	O
Flush	O
with	O
10mL	O
Normal	O
Saline	O
followed	O
by	O
Heparin	O
as	O
above	O
daily	O
and	O
PRN	O
per	O
lumen.	O
21.	O
cyclobenzaprine	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
22.	O
Meropenem	O
500	O
mg	O
IV	O
Q6H	O
Day	O
1	O
=	O
___.	O
ascorbic	O
acid	O
___	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
24.	O
carbamazepine	O
100	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
once	O
a	O
day:	O
Daily	O
at	O
noon.	O
25.	O
carbamazepine	O
300	O
mg	O
Cap,	O
ER	O
Multiphase	O
12	O
hr	O
Sig:	O
One	O
(1)	O
Cap,	O
ER	O
Multiphase	O
12	O
hr	O
PO	O
twice	O
a	O
day.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSIS:	O
-	O
Sepsis	B-Urinary_tract_infection
from	O
a	O
urinary	B-Urinary_tract_infection
source	O
related	O
to	O
chronic	O
partial	O
obstruction	O
and	O
chronic	O
nephrolithiasis	O
-	O
Chronic	O
indwelling	O
Foley	O
and	O
Perc	O
nephrostomy	O
tube	O
on	O
Left	O
-	O
Demand	O
cardiac	O
ischemia	O
SECONDARY	O
DIAGNOSES:	O
-	O
Multiple	O
Sclerosis	O
Discharge	O
Condition:	O
Level	O
of	O
Consciousness:	O
Lethargic	O
but	O
arousable.	O
Activity	O
Status:	O
Bedbound.	B-Bed_Chairbound
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Discharge	O
Instructions:	O
Ms.	O
___,	O
it	O
was	O
a	O
pleasure	O
to	O
participate	O
in	O
your	O
care	O
while	O
you	O
were	O
at	O
___.	O
You	O
came	O
to	O
the	O
hospital	O
after	O
you	O
were	O
found	O
unresponsive.	O
You	O
were	O
admitted	O
to	O
the	O
MICU	O
where	O
you	O
were	O
ultimately	O
found	O
to	O
have	O
septic	O
shock	O
due	O
to	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
and	O
a	O
large	O
infected	O
kidney	O
stone.	O
You	O
were	O
evaluated	O
by	O
several	O
specialists	O
including	O
the	O
infectious	O
disease	O
team	O
and	O
the	O
urology	O
team.	O
You	O
antibiotics	O
were	O
changed	O
while	O
you	O
were	O
here.	O
You	O
will	O
need	O
to	O
follow	O
up	O
with	O
your	O
urologist	O
for	O
kidney	O
stone	O
removal	O
in	O
the	O
near	O
future.	O
Followup	O
Instructions:	O
___	O

